237 related articles for article (PubMed ID: 36382667)
1. Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.
Sui L; Zeng J; Zhao H; Ye L; Martin TA; Sanders AJ; Ruge F; Jiang A; Dou QP; Hargest R; Song X; Jiang WG
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36382667
[TBL] [Abstract][Full Text] [Related]
2. Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the β-catenin/LGR5/Bcl-2 axis.
Jia Y; Li Z; Cheng X; Wu X; Pang F; Shi J; Li S; Li X; Hu Y; Zhang L; Ji J
J Investig Med; 2019 Jun; 67(5):856-861. PubMed ID: 30792218
[TBL] [Abstract][Full Text] [Related]
3. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer.
Sui L; Ye L; Sanders AJ; Yang Y; Hao C; Hargest R; Jiang WG
Anticancer Res; 2021 May; 41(5):2357-2362. PubMed ID: 33952460
[TBL] [Abstract][Full Text] [Related]
4. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Anticancer Res; 2012 Feb; 32(2):671-4. PubMed ID: 22287761
[TBL] [Abstract][Full Text] [Related]
5. Death-associated Protein 3 Regulates Mitochondrial-encoded Protein Synthesis and Mitochondrial Dynamics.
Xiao L; Xian H; Lee KY; Xiao B; Wang H; Yu F; Shen HM; Liou YC
J Biol Chem; 2015 Oct; 290(41):24961-74. PubMed ID: 26306039
[TBL] [Abstract][Full Text] [Related]
6. DELE1 is protective for mitochondrial cardiomyopathy.
Huynh H; Zhu S; Lee S; Bao Y; Pang J; Nguyen A; Gu Y; Chen C; Ouyang K; Evans SM; Fang X
J Mol Cell Cardiol; 2023 Feb; 175():44-48. PubMed ID: 36539111
[TBL] [Abstract][Full Text] [Related]
7. DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells.
Sato Y; Yoshino H; Kashiwakura I; Tsuruga E
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401559
[TBL] [Abstract][Full Text] [Related]
8. Functional role of death-associated protein 3 (DAP3) in anoikis.
Miyazaki T; Shen M; Fujikura D; Tosa N; Kim HR; Kon S; Uede T; Reed JC
J Biol Chem; 2004 Oct; 279(43):44667-72. PubMed ID: 15302871
[TBL] [Abstract][Full Text] [Related]
9. Effects of the knockdown of death-associated protein 3 expression on cell adhesion, growth and migration in breast cancer cells.
Wazir U; Sanders AJ; Wazir AM; Ye L; Jiang WG; Ster IC; Sharma AK; Mokbel K
Oncol Rep; 2015 May; 33(5):2575-82. PubMed ID: 25738636
[TBL] [Abstract][Full Text] [Related]
10. A mitochondrial iron-responsive pathway regulated by DELE1.
Sekine Y; Houston R; Eckl EM; Fessler E; Narendra DP; Jae LT; Sekine S
Mol Cell; 2023 Jun; 83(12):2059-2076.e6. PubMed ID: 37327776
[TBL] [Abstract][Full Text] [Related]
11. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
[TBL] [Abstract][Full Text] [Related]
13. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
14. mtDNA controls expression of the Death Associated Protein 3.
Jacques C; Chevrollier A; Loiseau D; Lagoutte L; Savagner F; Malthièry Y; Reynier P
Exp Cell Res; 2006 Apr; 312(6):737-45. PubMed ID: 16413536
[TBL] [Abstract][Full Text] [Related]
15. Death-associated protein 3 regulates cellular senescence through oxidative stress response.
Murata Y; Wakoh T; Uekawa N; Sugimoto M; Asai A; Miyazaki T; Maruyama M
FEBS Lett; 2006 Nov; 580(26):6093-9. PubMed ID: 17056041
[TBL] [Abstract][Full Text] [Related]
16. Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.
Li J; Ye L; Sun PH; Zheng F; Ruge F; Satherley LK; Feng Y; Zhao H; Du G; Wang T; Yang Y; Ma X; Cheng S; Yang X; Yu H; Teng X; Si Y; Zhang Z; Jiang WG
Oncotarget; 2017 Apr; 8(16):26231-26244. PubMed ID: 28412738
[TBL] [Abstract][Full Text] [Related]
17. Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer.
Han J; An O; Ren X; Song Y; Tang SJ; Shen H; Ke X; Ng VHE; Tay DJT; Tan HQ; Kappei D; Yang H; Chen L
Nat Commun; 2022 Apr; 13(1):1793. PubMed ID: 35379802
[TBL] [Abstract][Full Text] [Related]
18. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
19. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer.
Zhang Z; Feng L; Liu P; Duan W
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206
[TBL] [Abstract][Full Text] [Related]
20. Identification of phosphorylation sites in mammalian mitochondrial ribosomal protein DAP3.
Miller JL; Koc H; Koc EC
Protein Sci; 2008 Feb; 17(2):251-60. PubMed ID: 18227431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
